Axsome Therapeutics Inc (AXSM)

Oct 16, 2025

Is Axsome Therapeutics Inc a good long term investmentEarnings Volatility Patterns & Grow Generational Wealth With Ease - earlytimes.in

Oct 16, 2025

Oct 16, 2025

Is Axsome Therapeutics Inc. stock gaining market shareTrade Risk Assessment & Weekly Stock Performance Updates - newser.com

Oct 16, 2025

Oct 16, 2025

(AXSM) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com

Oct 16, 2025

Oct 16, 2025

How Axsome Therapeutics Inc. stock performs in rate cut cyclesTrade Risk Report & Safe Entry Point Identification - newser.com

Oct 16, 2025

Oct 15, 2025

Will Axsome Therapeutics Inc. (19X) stock outperform global peersJuly 2025 PreEarnings & Long Hold Capital Preservation Plans - newser.com

Oct 15, 2025

Oct 15, 2025

How Axsome Therapeutics Inc. stock compares to market leadersBond Market & Long-Term Safe Investment Plans - newser.com

Oct 15, 2025

Oct 15, 2025

Q2 EPS Forecast for Axsome Therapeutics Lifted by Analyst - MarketBeat

Oct 15, 2025

Oct 15, 2025

Can Axsome Therapeutics Inc. stock withstand economic slowdownRecession Risk & Real-Time Stock Price Movement Reports - newser.com

Oct 15, 2025

Oct 15, 2025

Top chart patterns to watch in Axsome Therapeutics Inc.2025 Stock Rankings & Real-Time Volume Triggers - newser.com

Oct 15, 2025

Oct 15, 2025

KLP Kapitalforvaltning AS Raises Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Oct 15, 2025

Oct 14, 2025

What candlestick patterns are forming on Axsome Therapeutics Inc.Analyst Downgrade & Precise Swing Trade Entry Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

Axsome Therapeutics Inc. stock volume spike explainedShare Buyback & AI Powered Market Entry Ideas - newser.com

Oct 14, 2025

Oct 13, 2025

Will Axsome Therapeutics Inc. (19X) stock deliver stable dividendsMarket Movers & Fast Entry Momentum Trade Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

Axsome Therapeutics Inc. stock trend forecast2025 Geopolitical Influence & Proven Capital Preservation Methods - newser.com

Oct 13, 2025

Oct 13, 2025

Tools to assess Axsome Therapeutics Inc.’s risk profileQuarterly Risk Review & Long-Term Capital Growth Strategies - newser.com

Oct 13, 2025

Oct 13, 2025

Axsome Therapeutics (AXSM) Stock Analysis: Unpacking A Potential 45% Upside In Biotech - DirectorsTalk Interviews

Oct 13, 2025

Oct 13, 2025

Axsome Therapeutics, Inc. $AXSM Shares Sold by Blair William & Co. IL - MarketBeat

Oct 13, 2025

Oct 13, 2025

What is William Blair's Estimate for AXSM FY2026 Earnings? - MarketBeat

Oct 13, 2025

Oct 12, 2025

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Grows Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Oct 12, 2025

Oct 11, 2025

IFP Advisors Inc Sells 4,096 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

Oct 11, 2025

Oct 10, 2025

Q3 EPS Estimate for Axsome Therapeutics Reduced by Analyst - MarketBeat

Oct 10, 2025

Oct 10, 2025

Can trapped investors hope for a rebound in Axsome Therapeutics Inc.Gap Up & Verified Stock Trade Ideas - newser.com

Oct 10, 2025

Oct 10, 2025

Axsome Therapeutics' Strong Growth And Expanding Pipeline: Why I Assign A Buy Rating - Seeking Alpha

Oct 10, 2025

Oct 09, 2025

Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $1,590,330.30 in Stock - MarketBeat

Oct 09, 2025

Oct 09, 2025

Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $1,518,062.16 in Stock - MarketBeat

Oct 09, 2025

Oct 09, 2025

Herriot Tabuteau Sells 19,220 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat

Oct 09, 2025

Oct 09, 2025

Axsome Therapeutics (NASDAQ:AXSM) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

Axsome Therapeutics (AXSM): Exploring Valuation After Recent Share Price Stability - Yahoo Finance

Oct 09, 2025

Oct 09, 2025

Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community - The Manila Times

Oct 09, 2025

Oct 09, 2025

Real time social sentiment graph for Axsome Therapeutics Inc.Weekly Profit Recap & AI Driven Price Forecasts - newser.com

Oct 09, 2025

Oct 09, 2025

1 in 5 U.S. adults affected — Axsome Recognizes Mental Illness Awareness Week and shares NAMI resources - Stock Titan

Oct 09, 2025

Oct 09, 2025

Axsome therapeutics CEO sells $5.4m in shares By Investing.com - Investing.com Canada

Oct 09, 2025

Oct 08, 2025

Axsome therapeutics CEO sells $5.4m in shares - Investing.com

Oct 08, 2025

Oct 08, 2025

Leerink Partnrs Issues Positive Forecast for AXSM Earnings - MarketBeat

Oct 08, 2025

Oct 07, 2025

Axsome Therapeutics Schedule Third Quarter 2025 Financial Results Announcement and Conference Call - Quiver Quantitative

Oct 07, 2025

Oct 07, 2025

Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3 - The Manila Times

Oct 07, 2025

Oct 07, 2025

Knights of Columbus Asset Advisors LLC Grows Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Oct 07, 2025

Oct 07, 2025

Q3 2025 Results Nov 3: Axsome Therapeutics to Report Results and Host 8:00 AM ET Conference Call; Webcast - Stock Titan

Oct 07, 2025

Oct 06, 2025

Is Axsome Therapeutics Inc 19X a good long term investmentVolatility Adjusted Trading & Free Trading Psychology Sessions - earlytimes.in

Oct 06, 2025

Oct 04, 2025

J. Safra Sarasin Holding AG Purchases 9,998 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

Oct 04, 2025

Oct 03, 2025

Meet Herriot Tabuteau, The Haitian-Born Doctor Whose Brain Disorder Medications Turned Into A $6 Billion Empire - Black Enterprise

Oct 03, 2025

Oct 03, 2025

What is B. Riley's Estimate for AXSM Q3 Earnings? - MarketBeat

Oct 03, 2025

Oct 02, 2025

Piper Sandler Maintains Overweight on Axsome (AXSM), Sees Growth in AD-Agitation - Yahoo Finance

Oct 02, 2025

Oct 02, 2025

Migraine Market Growth to Surge During Forecast Period (2024–2034), Says DelveInsight | Eli Lilly and Company, Teva Pharmaceuticals, Axsome Therapeutics, AEON Biopharma, Inc., Charleston Laboratories - Barchart.com

Oct 02, 2025

Oct 02, 2025

Axsome Therapeutics (NASDAQ:AXSM) Upgraded by B. Riley to Strong-Buy Rating - MarketBeat

Oct 02, 2025